<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chan W</submitter><funding>NEI NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>105988</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9547607</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(9)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Acute central retinal artery occlusion (CRAO) is an emergency with poor visual outcome. Intravenous thrombolysis within 4.5 h of vision loss is safe and may improve vision, but is rarely administered because of frequent delays in presentation. We describe a subgroup of CRAO patients presenting within 24 h of vision loss to a tertiary care center affiliated with a comprehensive stroke center.&lt;h4>Materials and methods&lt;/h4>Retrospective review of 181 consecutive CRAO patients seen at our institution from 2010 to 2020.&lt;h4>Results&lt;/h4>Out of 181 CRAO patients, 62 (34%) presented within 24 h of vision loss and tended to live closer to the hospital. These patients were more likely to be admitted to the hospital and receive comprehensive stroke work-up compared to patients who pr</pubmed_abstract><journal>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</journal><pubmed_title>Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution.</pubmed_title><pmcid>PMC9547607</pmcid><funding_grant_id>P30 EY006360</funding_grant_id><funding_grant_id>R01 NS089694</funding_grant_id><pubmed_authors>Chan W</pubmed_authors><pubmed_authors>Flowers AM</pubmed_authors><pubmed_authors>Meyer BI</pubmed_authors><pubmed_authors>Bruce BB</pubmed_authors><pubmed_authors>Biousse V</pubmed_authors><pubmed_authors>Newman NJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution.</name><description>&lt;h4>Objective&lt;/h4>Acute central retinal artery occlusion (CRAO) is an emergency with poor visual outcome. Intravenous thrombolysis within 4.5 h of vision loss is safe and may improve vision, but is rarely administered because of frequent delays in presentation. We describe a subgroup of CRAO patients presenting within 24 h of vision loss to a tertiary care center affiliated with a comprehensive stroke center.&lt;h4>Materials and methods&lt;/h4>Retrospective review of 181 consecutive CRAO patients seen at our institution from 2010 to 2020.&lt;h4>Results&lt;/h4>Out of 181 CRAO patients, 62 (34%) presented within 24 h of vision loss and tended to live closer to the hospital. These patients were more likely to be admitted to the hospital and receive comprehensive stroke work-up compared to patients who pr</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-22T21:52:33.322Z</modification><creation>2025-02-19T01:28:13.382Z</creation></dates><accession>S-EPMC9547607</accession><cross_references><pubmed>34271275</pubmed><doi>10.1016/j.jstrokecerebrovasdis.2021.105988</doi></cross_references></HashMap>